Clinical trial · Observational
Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
NCT02873117CI-TRIAL-00031819CANARIcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter, cohort study based on medico-administrative data from pathology laboratory registries and drug reimbursement files (CNAM-TS).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Prostate Hyperplasia | Benign Prostatic Hyperplasia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Prostate biopsy, prostatectomy or prostate resection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 5 alpha reductase inhibitor
- interventionNames
- Other: Prostate biopsy, prostatectomy or prostate resection
- label
- Any other drug for benign prostate hyperplasia
- interventionNames
- Other: Prostate biopsy, prostatectomy or prostate resection
Primary outcomes (1)
- measure
- High grade (Gleason >= 7) prostate cancer
- timeFrame
- Day 1
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Men with a reimbursement of any pharmacologic treatment patented for symptomatic benign prostate hyperplasia between January 1st 2010 and December 31st 2011, affiliated to French health system and living in Brittany, France. Exclusion Criteria: * Prostate cancer with a date of diagnosis before December 31st, 2011, patients enrolled in surveillance program with scheduled prostate biopsy, patients not affiliated to French health system.
References
Publications (0)
Data not yet available
No reference posted for this study.